PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

Logo of bmcpediBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Pediatrics
 
From:
Published online Jun 19, 2012. doi: 10.1186/1471-2431-12-78
Table 2
Annual prevalence (2003–2008) of pharmacologically treated ADHD (methylphenidate, dexamfetamine and atomoxetine) by age category and gender
Age CategoryYear200320042005200620072008
Total Prevalence*1000 (Males and Females  6 years)
0.709
0.862
1.014
1.203
1.365
1.403
95% Cl (lb)*1000
0.676
0.825
0.975
1.161
1.320
1.358
95% Cl (ub)*1000
0.743
0.899
1.054
1.246
1.411
1.449
6-12 years
Female Prevalence*1000
1.339
1.642
2.042
2.310
2.775
2.769
95% Cl (lb)*1000
1.131
1.411
1.784
2.034
2.470
2.464
95% Cl (ub)*1000
1.574
1.900
2.327
2.613
3.108
3.101
Male Prevalence*1000
8.147
9.758
11.133
13.224
15.432
15.321
95% Cl (lb)*1000
7.634
9.195
10.532
12.566
14.716
14.607
95% Cl (ub)*1000
8.685
10.346
11.759
13.907
16.174
16.061
Total Prevalence*1000
4.825
5.795
6.688
7.886
9.241
9.181
95% Cl (lb)*1000
4.543
5.485
6.355
7.522
8.844
8.786
95% Cl (ub)*1000
5.121
6.119
7.034
8.262
9.651
9.590
13-17 years
Female Prevalence*1000
0.635
0.947
1.106
1.446
1.767
2.002
95% Cl (lb)*1000
0.465
0.742
0.890
1.201
1.497
1.714
95% Cl (ub)*1000
0.847
1.191
1.360
1.727
2.071
2.325
Male Prevalence*1000
6.250
7.535
9.104
11.027
11.752
12.569
95% Cl (lb)*1000
5.719
6.963
8.485
10.350
11.054
11.845
95% Cl (ub)*1000
6.818
8.141
9.757
11.737
12.483
13.325
Total Prevalence*1000
3.608
4.404
5.265
6.378
6.865
7.396
95% Cl (lb)*1000
3.314
4.087
4.925
6.008
6.484
6.999
95% Cl (ub)*1000
3.921
4.739
5.622
6.765
7.264
7.810
18-24 years
Female Prevalence*1000
0.118
0.116
0.112
0.244
0.337
0.335
95% Cl (lb)*1000
0.059
0.058
0.056
0.158
0.236
0.237
95% Cl (ub)*1000
0.211
0.207
0.200
0.361
0.466
0.460
Male Prevalence*1000
0.396
0.521
0.845
0.943
1.385
1.876
95% Cl (lb)*1000
0.283
0.391
0.679
0.770
1.178
1.637
95% Cl (ub)*1000
0.540
0.680
1.038
1.142
1.619
2.140
Total Prevalence*1000
0.263
0.327
0.493
0.607
0.878
1.122
95% Cl (lb)*1000
0.196
0.253
0.402
0.507
0.759
0.989
95% Cl (ub)*1000
0.346
0.417
0.599
0.721
1.010
1.267
25-45 years
Female Prevalence*1000
0.008
0.026
0.028
0.040
0.045
0.052
95% Cl (lb)*1000
0.002
0.012
0.014
0.023
0.027
0.032
95% Cl (ub)*1000
0.023
0.047
0.050
0.065
0.071
0.079
Male Prevalence*1000
0.025
0.038
0.052
0.074
0.095
0.105
95% Cl (lb)*1000
0.012
0.021
0.032
0.050
0.068
0.076
95% Cl (ub)*1000
0.046
0.062
0.079
0.105
0.130
0.141
Total Prevalence*1000
0.017
0.032
0.040
0.057
0.070
0.079
95% Cl (lb)*1000
0.009
0.021
0.027
0.042
0.053
0.061
95% Cl (ub)*1000
0.028
0.047
0.056
0.076
0.091
0.100
>45 years
Female Prevalence*1000
0.007
0.011
0.007
0.010
0.010
0.011
95% Cl (lb)*1000
0.002
0.004
0.002
0.004
0.004
0.005
95% Cl (ub)*1000
0.018
0.023
0.018
0.022
0.022
0.024
Male Prevalence*1000
0.008
0.008
0.015
0.015
0.020
0.027
95% Cl (lb)*1000
0.002
0.002
0.007
0.006
0.010
0.015
95% Cl (ub)*1000
0.020
0.020
0.030
0.029
0.036
0.044
Total Prevalence*1000
0.008
0.009
0.011
0.012
0.015
0.019
95% Cl (lb)*1000
0.003
0.004
0.006
0.007
0.009
0.012
95% Cl (ub)*10000.0150.0170.0190.0210.0240.028
CI (Confidence Interval), lb (lower boundary) and ub (upper boundary).
Articles from BMC Pediatrics are provided here courtesy of
BioMed Central